The Canadian government and European Union (EU) are currently negotiating a Comprehensive Economic and Trade Agreement (CETA). A key issue has been ensuring that Canadian
In a move with far reaching implications for the debates around pharmaceutical patents, innovation and access to medicines, the Indian patent office issued its first
On January 21, the WHO 130th WHO Executive Board (EB) adopted a resolution for agenda item 6.13 “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” [SFFC]. The resolution is intended
Access to information is generally important in a free and democratic society. It’s particularly important in the context of regulating drugs, medical devices, and other
Lena Vartanian is a JD candidate at Osgoode Hall Law School and is enrolled in Professor Mgbeoji’s Patents class in Fall 2011. As part of
Dr. Ron Bouchard is an Associate Professor in the Faculties of Law and of Medicine at the University of Manitoba, a CIHR New Investigator and
